
Interim Healthcare Inc.
Franchise research report · reviewed 2026 disclosure data
Researching Interim Healthcare Inc. franchise opportunities? Every figure below is cited to the FDD.
INTERIM franchise specializes in providing healthcare staffing services, connecting qualified medical professionals with hospitals, clinics, and other healthcar
Headline figures
Interim Healthcare Inc. quick facts
- Is Interim Healthcare Inc. a franchise?
- Yes. Interim Healthcare Inc. offers franchises through a Franchise Disclosure Document. At the end of 2025, it reported 209 outlets in total (2026 FDD, Item 20, PDF p. 74).
- How much does it cost to open an Interim Healthcare Inc. franchise?
- The Interim Healthcare Inc. Franchise Disclosure Document reports an estimated initial investment of $422,150–$628,000 (2026 FDD, Item 7, PDF p. 38). This is the franchisor's disclosed estimate, not a quote. Details
- What ongoing fees does Interim Healthcare Inc. charge?
- The disclosed ongoing royalty is 3.5% (2026 FDD, Item 6, PDF p. 28). Other recurring fees are listed in Item 6. Details
- Does Interim Healthcare Inc. disclose financial performance (Item 19)?
- Yes. The Interim Healthcare Inc. FDD includes an Item 19 financial performance representation (2026 FDD, Item 19, PDF p. 69). Figures apply only to the locations and period each one covers. Details
- How many Interim Healthcare Inc. locations are there?
- The FDD reports 209 outlets at the end of 2025 (2026 FDD, Item 20, PDF p. 74). Existing locations do not indicate territory availability. Details
- Is Interim Healthcare Inc. a good franchise to buy?
- Franopolis does not rate or recommend franchises. From the reviewed FDD: Item 19 includes financial performance figures; check which locations and period they cover; Item 20 lists outlet openings, closures and transfers; Item 6 lists every recurring fee beyond royalty; Item 20 also lists current and former franchisees you can contact. Review the full FDD with a franchise attorney and accountant before deciding.
From reviewed FDD figures only. Not a recommendation or projection.
What the disclosures show
- 1Opening costs are estimated at $422,150 – $628,000 in the 2026 FDD (Item 7); several initial fee options apply.
- 2Item 19 covers 40 separate groups: other measures for 10 Franchised locations; other measures for 10 Franchised locations; other measures for 50 Franchised locations; other measures for 50 Franchised locations; other measures for 168 Franchised locations; other measures for 165 Franchised locations; other measures for 150 Franchised locations; other measures for 65 Franchised locations; other measures for 64 Franchised locations; other measures for 70 Franchised locations; other measures for 22 Franchised locations; other measures for 18 Franchised locations; other measures for 20 Franchised locations; other measures for 19 Franchised locations; other measures for 17 Franchised locations; other measures for 10 Franchised locations; other measures for 19 Franchised locations; other measures for 2 Franchised locations; other measures for 51 Franchised locations; other measures for 38 Franchised locations; other measures for 106 Franchised locations; other measures for 11 Franchised locations; other measures for 32 Franchised locations; other measures for 34 Franchised locations; other measures for 1 Franchised locations; other measures for 88 Franchised locations; other measures for 1 Franchised locations; other measures for 23 Franchised locations; other measures for 36 Franchised locations; other measures for 90 Franchised locations; other measures for 6 Franchised locations; other measures for 2 Franchised locations; other measures for 19 Franchised locations; other measures for 2 Franchised locations; other measures for 4 Franchised locations; other measures for 14 Franchised locations; other measures for 3 Franchised locations; other measures for 13 Franchised locations; other measures for 10 Franchised franchisee; other measures for 10 Franchised locations. They are not combined.
- 3Outlets declined by 26 in 2025, to 209 (United States, as labeled in the FDD, Item 20).
From reviewed FDD figures only. Not a recommendation or projection.
Interim Healthcare Inc. head-to-head
Closest peers in the same subcategory, side by side from reviewed FDD figures. Not a ranking or recommendation.
Costs · Items 5–7
What does it cost to open?
Estimated opening costs and the fees payable to the franchisor.
Startup Investment — Item 7
Total estimated initial investment
2026 FDD · Item 7 · PDF p. 38
Ongoing Fees — Item 6
Selected recurring charges; payment bases and conditions remain attached to each fee.
- Ongoing fees, royalty basis and quotas — 3.5%Main ongoing fee
65 reported fees, each with its payment basis, are listed below; they haven't been sorted into recurring, initial and occasional groups yet.
Financial Performance — Item 19
What results are disclosed—and for which locations?
40 separate populations, shown apart. Revenue is not owner income.
10 locations
Other measures · 10 locations
- Who is counted
- Part2 bottom10 hospice territories
- Period
- Highest Gross Revenue
- Excluded
- Hospice sales only; full-year22of28territories2025,20in2024,18in2023.
- Method
- Historical franchisee reporting; full-year sales only, no operating expenses or fees deducted. Source figures retained without recalculation.
These groups are never combined.
Outlet Changes — Item 20
How has the outlet count changed?
United States, as labeled in the FDD · counts as of 2025 of each year.
2026 FDD · Item 20 · PDF p. 74
Net −29 outlets, 2023–2025
Year-end counts reported in Item 20. The scale starts at zero; the labels between the dots show each year's change. Openings and closures for 2025 haven't been pulled from the Item 20 tables yet, so no turnover or churn is shown.
Questions to investigate
Prompts based on what this brand's reviewed disclosures do and don't show — not conclusions. Join free as a member to save questions to your research.
For the franchisor
Which line items in the 2026 Item 7 estimate ($422,150 – $628,000) vary most by market, and why?
Which initial fee option would apply to my situation, and what conditions or discounts affect it?
Which locations are included in the Item 19 figures, and which were excluded?
Reported units decreased from 235 to 209 in 2025. What drove the change?
Is a territory available in my area, and how is it defined in my agreement?
For current and former owners
How did your actual startup costs and timeline compare with the Item 7 estimate?
How many hours a week do you work in the business, and in what role?
How do your results compare with the Item 19 figures, and what explains the difference?
What support from the franchisor has been most and least useful?
For your advisors
Ask a franchise attorney to review the territory, renewal, transfer and termination terms.
Ask an accountant to build a cash-flow plan using your own assumptions, not the franchisor's.
Sources & vintage history
Every displayed fact is retained with its disclosure vintage, item, page, and reviewed status. Prior vintages remain on file rather than being overwritten.
Citations (2026 FDD)
- [1]Estimated initial investment — Item 7 · PDF p. 38
- [2]Item 19 — Locations counted not stated in the reviewed record — Part2 bottom10 hospice territories · PDF p. 69
- [3]Item 19 — Locations counted not stated in the reviewed record — Part2 top10 hospice territories · PDF p. 69
- [4]Item 19 — Locations counted not stated in the reviewed record — Part1 top50 healthcare territories · PDF p. 64
- [5]Item 19 — Locations counted not stated in the reviewed record — Part1 bottom50 healthcare territories · PDF p. 65
- [6]Item 19 — Locations counted not stated in the reviewed record — Part1 all healthcare territories · PDF p. 65; PDF p. 66
- [7]Item 19 — Locations counted not stated in the reviewed record — Part1 all healthcare territories · PDF p. 65; PDF p. 66
- [8]Item 19 — Locations counted not stated in the reviewed record — Part1 all healthcare territories · PDF p. 65; PDF p. 66
- [9]Item 19 — Locations counted not stated in the reviewed record — Part1 all healthcare territories — single-territory owners only · PDF p. 66
- [10]Item 19 — Locations counted not stated in the reviewed record — Part1 all healthcare territories — single-territory owners only · PDF p. 66
- [11]Item 19 — Locations counted not stated in the reviewed record — Part1 all healthcare territories — single-territory owners only · PDF p. 66
- [12]Item 19 — Locations counted not stated in the reviewed record — Part2 all hospice territories · PDF p. 70
- [13]Item 19 — Locations counted not stated in the reviewed record — Part2 all hospice territories · PDF p. 70
- [14]Item 19 — Locations counted not stated in the reviewed record — Part2 all hospice territories · PDF p. 70
- [15]Item 19 — Locations counted not stated in the reviewed record — Part 2 all hospice territories — single-territory owners only · PDF p. 70
- [16]Item 19 — Locations counted not stated in the reviewed record — Part2 all hospice territories — single-territory owners only · PDF p. 70
- [17]Item 19 — Locations counted not stated in the reviewed record — Part2 all hospice territories — single-territory owners only · PDF p. 70
- [18]Item 19 — Locations counted not stated in the reviewed record — Part2 all hospice territories — single-territory owners only · PDF p. 70
- [19]Item 19 — Locations counted not stated in the reviewed record — Home healthcare territories; time in system Less than 3 Years · PDF p. 67
- [20]Item 19 — Locations counted not stated in the reviewed record — Home healthcare territories; time in system 3 - 5 Years · PDF p. 67
- [21]Item 19 — Locations counted not stated in the reviewed record — Home healthcare territories; time in system 5 - 10 Years · PDF p. 67
- [22]Item 19 — Locations counted not stated in the reviewed record — Home healthcare territories; time in system Over 10 Years · PDF p. 67
- [23]Item 19 — Locations counted not stated in the reviewed record — Home healthcare territories; time in system Less than 3 Years · PDF p. 67; PDF p. 68
- [24]Item 19 — Locations counted not stated in the reviewed record — Home healthcare territories; time in system 3 - 5 Years · PDF p. 67; PDF p. 68
- [25]Item 19 — Locations counted not stated in the reviewed record — Home healthcare territories; time in system 5 - 10 Years · PDF p. 67; PDF p. 68
- [26]Item 19 — Locations counted not stated in the reviewed record — Hospice territories; time in system 3 - 5 Years · PDF p. 71
- [27]Item 19 — Locations counted not stated in the reviewed record — Home healthcare territories; time in system Over 10 Years · PDF p. 67; PDF p. 68
- [28]Item 19 — Locations counted not stated in the reviewed record — Home healthcare territories; time in system Less than 3 Years · PDF p. 68
- [29]Item 19 — Locations counted not stated in the reviewed record — Home healthcare territories; time in system 3 - 5 Years · PDF p. 68
- [30]Item 19 — Locations counted not stated in the reviewed record — Home healthcare territories; time in system 5 - 10 Years · PDF p. 68
- [31]Item 19 — Locations counted not stated in the reviewed record — Home healthcare territories; time in system Over 10 Years · PDF p. 68
- [32]Item 19 — Locations counted not stated in the reviewed record — Hospice territories; time in system 5 - 10 Years · PDF p. 71
- [33]Item 19 — Locations counted not stated in the reviewed record — Hospice territories; time in system Less than 3 Years · PDF p. 71
- [34]Item 19 — Locations counted not stated in the reviewed record — Hospice territories; time in system Over 10 Years · PDF p. 71
- [35]Item 19 — Locations counted not stated in the reviewed record — Hospice territories; time in system 3 - 5 Years · PDF p. 71; PDF p. 72
- [36]Item 19 — Locations counted not stated in the reviewed record — Hospice territories; time in system 5 - 10 Years · PDF p. 71
- [37]Item 19 — Locations counted not stated in the reviewed record — Hospice territories; time in system Over 10 Years · PDF p. 71
- [38]Item 19 — Locations counted not stated in the reviewed record — Hospice territories; time in system 5 - 10 Years · PDF p. 71; PDF p. 72
- [39]Item 19 — Locations counted not stated in the reviewed record — Hospice territories; time in system Over 10 Years · PDF p. 71; PDF p. 72
- [40]Item 19 — Locations counted not stated in the reviewed record — Top 10 franchisee-operated Hospice Territories for 2023, from the 18 territorie… · PDF p. 69
- [41]Item 19 — Locations counted not stated in the reviewed record — Part 2 all hospice territories — single-territory owners only · PDF p. 70
- [42]Outlet counts — Item 20, Table 1 · PDF p. 74
"PDF p." is the page in the PDF file; "printed p." is the number printed on the FDD page. Source document: FDD
Territory & operations
These are contract disclosures, not confirmation that any territory is currently available.
Legal & agreement
Franchisor financial statements
| Fiscal year | Measure | Reported value |
|---|---|---|
| 2025 | restricted cash with fiscal agents | $162 |
| 2025 | accounts receivable net | $1,969 |
| 2025 | note receivableMore than one value recorded for this year — open the FDD source before comparing | $445 |
| 2025 | note receivable from related party | $412 |
| 2025 | other current assets | $2,208 |
| 2025 | total current assets | $10,662 |
| 2025 | trademarks | $53,518 |
| 2025 | property and equipment, net | $439 |
| 2025 | right of use asset, net | $78 |
| 2025 | total assets | $122,231 |
| 2025 | s equity current liabilities accounts payable | $7,313 |
| 2025 | accrued expenses | $4,796 |
These figures describe the franchisor company, not individual franchise locations.
SBA-backed loans to franchisees
Loading…
Source: U.S. Small Business Administration 7(a) & 504 FOIA data. Loan volume is not a measure of franchisee success.
At a glance
Business history
Not reviewed
Owner participation
Not reviewed
Territory language
Litigation disclosure
Not reviewed
Bankruptcy disclosure
Not reviewed
Agreement term
Not reviewed
Reader notes on wording
Our automated check found that these summaries may not match the FDD's exact wording. Read the FDD excerpt itself; it is the authoritative text. Core cost, fee, Item 19 and outlet figures are not affected.
Item 19 · PDF p. 69 · 2026 FDD
Our summary: Part2 top10 hospice territories 2024 — Highest Gross Revenue
“Highest Gross Revenue $15,316,282 $25,786.021 $19,408,099”
Note: The full page prints the 2024 highest revenue as “$25,786.021”; the punctuation leaves the amount ambiguous, and I cannot safely normalize it.
Item 19 · PDF p. 65 · 2026 FDD
Our summary: Part1 all healthcare territories 2025 — Highest Gross Revenue
“Highest Gross Revenue $57,621.347 $56,254,101 $52,665,377”
Note: The full all-territories row prints the 2025 highest revenue as “$57,621.347”; the punctuation makes the amount ambiguous. The matching top-50 figure is a different population, so I cannot use it to correct this claim.
Item 20 · PDF p. 74 · 2026 FDD
Our summary: Table 1 Company owned 2024 — Net change
“Franchised 2023 222 235 13 2024 235 231 - 4 202 5 231 201 - 30 Company- Owned 2023 5 3 -2 2024 3 4 1 202 5 4 8 4 Total Outlets 2023 227 238 11 2024 238 235 - 3 202 5 235 209 - 26 ”
Note: This is a systemwide Company-Owned row, not the systemwide Total row required for Item 20 checks.
Item 20 · PDF p. 76 · 2026 FDD
Our summary: Table 3 Connecticut 2024 — Terminations
“2024 3 0 0 0 0 0 3”
Note: This is a state-specific Table 3 outlet row. Item 20 checking is limited to systemwide or national Total rows.
Item 20 · PDF p. 76 · 2026 FDD
Our summary: Table 3 Connecticut 2024 — Reacquired
“2024 3 0 0 0 0 0 3”
Note: This is a state-specific Table 3 outlet row. Item 20 checking is limited to systemwide or national Total rows.
Item 20 · PDF p. 76 · 2026 FDD
Our summary: Table 3 Connecticut 2024 — Ceased other reasons
“2024 3 0 0 0 0 0 3”
Note: This is a state-specific Table 3 outlet row. Item 20 checking is limited to systemwide or national Total rows.
Item 20 · PDF p. 76 · 2026 FDD
Our summary: Table 3 Connecticut 2024 — Nonrenewals
“2024 3 0 0 0 0 0 3”
Note: This is a state-specific Table 3 outlet row. Item 20 checking is limited to systemwide or national Total rows.
Item 20 · PDF p. 76 · 2026 FDD
Our summary: Table 3 Connecticut 2024 — Opened
“2024 3 0 0 0 0 0 3”
Note: This is a state-specific Table 3 outlet row. Item 20 checking is limited to systemwide or national Total rows.
Item 20 · PDF p. 76 · 2026 FDD
Our summary: Table 3 Connecticut 2025 — Nonrenewals
“2025 3 0 0 0 0 2 1”
Note: This is a state-specific Table 3 outlet row. Item 20 checking is limited to systemwide or national Total rows.
Item 20 · PDF p. 76 · 2026 FDD
Our summary: Table 3 Connecticut 2025 — Opened
“2025 3 0 0 0 0 2 1”
Note: This is a state-specific Table 3 outlet row. Item 20 checking is limited to systemwide or national Total rows.
Item 20 · PDF p. 76 · 2026 FDD
Our summary: Table 3 Connecticut 2024 — End
“2024 3 0 0 0 0 0 3”
Note: This is a state-specific Table 3 outlet row. Item 20 checking is limited to systemwide or national Total rows.
Item 20 · PDF p. 76 · 2026 FDD
Our summary: Table 3 Connecticut 2025 — Start
“2025 3 0 0 0 0 2 1”
Note: This is a state-specific Table 3 outlet row. Item 20 checking is limited to systemwide or national Total rows.
Item 20 · PDF p. 76 · 2026 FDD
Our summary: Table 3 Delaware 2023 — Start
“2023 1 0 0 0 0 0 1”
Note: This is a state-specific Table 3 outlet row. Item 20 checking is limited to systemwide or national Total rows.
Item 20 · PDF p. 76 · 2026 FDD
Our summary: Table 3 Connecticut 2025 — Terminations
“2025 3 0 0 0 0 2 1”
Note: This is a state-specific Table 3 outlet row. Item 20 checking is limited to systemwide or national Total rows.
Item 20 · PDF p. 77 · 2026 FDD
Our summary: Table 3 Iowa 2025 — Nonrenewals
“2025 2 0 0 0 0 1 1”
Note: The cited Item 20 row is state or outlet-type data; the review scope permits national/systemwide Total rows only.
Item 20 · PDF p. 77 · 2026 FDD
Our summary: Table 3 Iowa 2024 — Nonrenewals
“2024 2 0 0 0 0 0 2”
Note: The cited Item 20 row is state or outlet-type data; the review scope permits national/systemwide Total rows only.
Item 20 · PDF p. 77 · 2026 FDD
Our summary: Table 3 Iowa 2024 — Reacquired
“2024 2 0 0 0 0 0 2”
Note: The cited Item 20 row is state or outlet-type data; the review scope permits national/systemwide Total rows only.
Item 20 · PDF p. 77 · 2026 FDD
Our summary: Table 3 Iowa 2025 — Reacquired
“2025 2 0 0 0 0 1 1”
Note: The cited Item 20 row is state or outlet-type data; the review scope permits national/systemwide Total rows only.
Item 20 · PDF p. 77 · 2026 FDD
Our summary: Table 3 Iowa 2024 — Ceased other reasons
“2024 2 0 0 0 0 0 2”
Note: The cited Item 20 row is state or outlet-type data; the review scope permits national/systemwide Total rows only.
Item 20 · PDF p. 77 · 2026 FDD
Our summary: Table 3 Kansas 2024 — Nonrenewals
“2024 3 0 0 0 0 0 3”
Note: The cited Item 20 row is state or outlet-type data; the review scope permits national/systemwide Total rows only.
Item 20 · PDF p. 77 · 2026 FDD
Our summary: Table 3 Kansas 2024 — Start
“2024 3 0 0 0 0 0 3”
Note: The cited Item 20 row is state or outlet-type data; the review scope permits national/systemwide Total rows only.
Item 20 · PDF p. 77 · 2026 FDD
Our summary: Table 3 Kansas 2024 — Ceased other reasons
“2024 3 0 0 0 0 0 3”
Note: The cited Item 20 row is state or outlet-type data; the review scope permits national/systemwide Total rows only.
Item 20 · PDF p. 77 · 2026 FDD
Our summary: Table 3 Kansas 2024 — Opened
“2024 3 0 0 0 0 0 3”
Note: The cited Item 20 row is state or outlet-type data; the review scope permits national/systemwide Total rows only.
Item 20 · PDF p. 77 · 2026 FDD
Our summary: Table 3 Kansas 2025 — Opened
“2025 3 0 0 0 0 0 3”
Note: The cited Item 20 row is state or outlet-type data; the review scope permits national/systemwide Total rows only.
Item 20 · PDF p. 77 · 2026 FDD
Our summary: Table 3 Kansas 2025 — Terminations
“2025 3 0 0 0 0 0 3”
Note: The cited Item 20 row is state or outlet-type data; the review scope permits national/systemwide Total rows only.
Item 20 · PDF p. 77 · 2026 FDD
Our summary: Table 3 Kansas 2023 — Nonrenewals
“2023 3 0 0 0 0 0 3”
Note: The cited Item 20 row is state or outlet-type data; the review scope permits national/systemwide Total rows only.
Item 20 · PDF p. 77 · 2026 FDD
Our summary: Table 3 Iowa 2025 — End
“2025 2 0 0 0 0 1 1”
Note: The cited Item 20 row is state or outlet-type data; the review scope permits national/systemwide Total rows only.
Item 20 · PDF p. 77 · 2026 FDD
Our summary: Table 3 Kansas 2023 — End
“2023 3 0 0 0 0 0 3”
Note: The cited Item 20 row is state or outlet-type data; the review scope permits national/systemwide Total rows only.
Item 20 · PDF p. 77 · 2026 FDD
Our summary: Table 3 Maryland 2023 — Ceased other reasons
“2023 6 1 1 0 0 0 6”
Note: The cited Item 20 row is state or outlet-type data; the review scope permits national/systemwide Total rows only.
Item 20 · PDF p. 77 · 2026 FDD
Our summary: Table 3 Kansas 2025 — Ceased other reasons
“2025 3 0 0 0 0 0 3”
Note: The cited Item 20 row is state or outlet-type data; the review scope permits national/systemwide Total rows only.
Item 20 · PDF p. 77 · 2026 FDD
Our summary: Table 3 Kansas 2025 — Reacquired
“2025 3 0 0 0 0 0 3”
Note: The cited Item 20 row is state or outlet-type data; the review scope permits national/systemwide Total rows only.
Item 20 · PDF p. 77 · 2026 FDD
Our summary: Table 3 Kentucky 2023 — End
“2023 1 0 0 0 0 1 0”
Note: The cited Item 20 row is state or outlet-type data; the review scope permits national/systemwide Total rows only.
Item 20 · PDF p. 77 · 2026 FDD
Our summary: Table 3 Maryland 2023 — End
“2023 6 1 1 0 0 0 6”
Note: The cited Item 20 row is state or outlet-type data; the review scope permits national/systemwide Total rows only.
Item 20 · PDF p. 77 · 2026 FDD
Our summary: Table 3 Kentucky 2023 — Reacquired
“2023 1 0 0 0 0 1 0”
Note: The cited Item 20 row is state or outlet-type data; the review scope permits national/systemwide Total rows only.
Item 20 · PDF p. 77 · 2026 FDD
Our summary: Table 3 Kentucky 2023 — Start
“2023 1 0 0 0 0 1 0”
Note: The cited Item 20 row is state or outlet-type data; the review scope permits national/systemwide Total rows only.
Item 20 · PDF p. 77 · 2026 FDD
Our summary: Table 3 Kentucky 2023 — Opened
“2023 1 0 0 0 0 1 0”
Note: The cited Item 20 row is state or outlet-type data; the review scope permits national/systemwide Total rows only.
Item 20 · PDF p. 77 · 2026 FDD
Our summary: Table 3 Maryland 2023 — Reacquired
“2023 6 1 1 0 0 0 6”
Note: The cited Item 20 row is state or outlet-type data; the review scope permits national/systemwide Total rows only.
Item 20 · PDF p. 77 · 2026 FDD
Our summary: Table 3 Maryland 2024 — Ceased other reasons
“2024 6 4 0 0 0 1 9”
Note: The cited Item 20 row is state or outlet-type data; the review scope permits national/systemwide Total rows only.
Item 20 · PDF p. 77 · 2026 FDD
Our summary: Table 3 Maryland 2024 — Terminations
“2024 6 4 0 0 0 1 9”
Note: The cited Item 20 row is state or outlet-type data; the review scope permits national/systemwide Total rows only.
Item 20 · PDF p. 77 · 2026 FDD
Our summary: Table 3 Maryland 2024 — End
“2024 6 4 0 0 0 1 9”
Note: The cited Item 20 row is state or outlet-type data; the review scope permits national/systemwide Total rows only.
Item 20 · PDF p. 77 · 2026 FDD
Our summary: Table 3 Maryland 2025 — Opened
“2025 9 0 0 0 0 1 8”
Note: The cited Item 20 row is state or outlet-type data; the review scope permits national/systemwide Total rows only.
Item 20 · PDF p. 77 · 2026 FDD
Our summary: Table 3 Maryland 2025 — Terminations
“2025 9 0 0 0 0 1 8”
Note: The cited Item 20 row is state or outlet-type data; the review scope permits national/systemwide Total rows only.
Item 20 · PDF p. 77 · 2026 FDD
Our summary: Table 3 Massachusetts 2023 — Start
“2023 3 0 0 0 0 0 3”
Note: This is a state-specific Table 3 outlet row. Item 20 checking is limited to systemwide or national Total rows.
Item 20 · PDF p. 77 · 2026 FDD
Our summary: Table 3 Maryland 2025 — End
“2025 9 0 0 0 0 1 8”
Note: The cited Item 20 row is state or outlet-type data; the review scope permits national/systemwide Total rows only.
Item 20 · PDF p. 77 · 2026 FDD
Our summary: Table 3 Maryland 2025 — Ceased other reasons
“2025 9 0 0 0 0 1 8”
Note: The cited Item 20 row is state or outlet-type data; the review scope permits national/systemwide Total rows only.
Item 20 · PDF p. 77 · 2026 FDD
Our summary: Table 3 Maryland 2024 — Reacquired
“2024 6 4 0 0 0 1 9”
Note: The cited Item 20 row is state or outlet-type data; the review scope permits national/systemwide Total rows only.
Item 20 · PDF p. 77 · 2026 FDD
Our summary: Table 3 Michigan 2023 — Start
“2023 8 2 1 0 0 0 9”
Note: The cited Item 20 row is state or outlet-type data; the review scope permits national/systemwide Total rows only.
Item 20 · PDF p. 77 · 2026 FDD
Our summary: Table 3 Michigan 2023 — Opened
“2023 8 2 1 0 0 0 9”
Note: The cited Item 20 row is state or outlet-type data; the review scope permits national/systemwide Total rows only.
Item 20 · PDF p. 77 · 2026 FDD
Our summary: Table 3 Michigan 2025 — End
“2025 9 1 0 0 0 0 10”
Note: The cited Item 20 row is state or outlet-type data; the review scope permits national/systemwide Total rows only.
Item 20 · PDF p. 77 · 2026 FDD
Our summary: Table 3 Michigan 2024 — Ceased other reasons
“2024 9 0 0 0 0 0 9”
Note: The cited Item 20 row is state or outlet-type data; the review scope permits national/systemwide Total rows only.
Independent analysis of franchisor-provided data. Not investment advice. Franopolis does not distribute FDDs.
Compare Interim Healthcare Inc. with…
VSCompare Interim Healthcare Inc. with…
VS



